» Articles » PMID: 26776051

Nanotechnology for Delivery of Peptide Nucleic Acids (PNAs)

Overview
Specialty Pharmacology
Date 2016 Jan 19
PMID 26776051
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past three decades, peptide nucleic acids have been employed in numerous chemical and biological applications. Peptide nucleic acids possess enormous potential because of their superior biophysical properties, compared to other oligonucleotide chemistries. However, for therapeutic applications, intracellular delivery of peptide nucleic acids remains a challenge. In this review, we summarize the progress that has been made in delivering peptide nucleic acids to intracellular targets. In addition, we emphasize recent nanoparticle-based strategies for efficient delivery of conventional and chemically-modified peptides nucleic acids.

Citing Articles

Efficient and selective kidney targeting by chemically modified carbohydrate conjugates.

Kumar V, Wahane A, Tham M, Somlo S, Gupta A, Bahal R Mol Ther. 2024; 32(12):4383-4400.

PMID: 39532098 PMC: 11638880. DOI: 10.1016/j.ymthe.2024.10.020.


Exploring the therapeutic potential of sγPNA-141: Pharmacodynamics and mechanistic insights during ischemic stroke recovery.

Yadav S, Dhuri K, Gamiotea-Turro D, Cormier M, Patel V, Yadawa A Mol Ther Nucleic Acids. 2024; 35(4):102355.

PMID: 39507400 PMC: 11539414. DOI: 10.1016/j.omtn.2024.102355.


Therapeutic and diagnostic applications of antisense peptide nucleic acids.

MacLelland V, Kravitz M, Gupta A Mol Ther Nucleic Acids. 2024; 35(1):102086.

PMID: 38204913 PMC: 10777018. DOI: 10.1016/j.omtn.2023.102086.


Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics.

Gasparello J, Papi C, Zurlo M, Volpi S, Gambari R, Corradini R Pharmaceutics. 2023; 15(8).

PMID: 37631335 PMC: 10460053. DOI: 10.3390/pharmaceutics15082121.


Variation of Tetrahydrofurans in Thyclotides Enhances Oligonucleotide Binding and Cellular Uptake of Peptide Nucleic Acids.

Zheng H, Clausse V, Amarasekara H, Mazur S, Botos I, Appella D JACS Au. 2023; 3(7):1952-1964.

PMID: 37502163 PMC: 10369417. DOI: 10.1021/jacsau.3c00198.


References
1.
Del C Monroig P, Chen L, Zhang S, Calin G . Small molecule compounds targeting miRNAs for cancer therapy. Adv Drug Deliv Rev. 2014; 81:104-16. PMC: 4461213. DOI: 10.1016/j.addr.2014.09.002. View

2.
Wang G, Seidman M, Glazer P . Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair. Science. 1996; 271(5250):802-5. DOI: 10.1126/science.271.5250.802. View

3.
OReilly R, Hawker C, Wooley K . Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. Chem Soc Rev. 2006; 35(11):1068-83. DOI: 10.1039/b514858h. View

4.
Tahara K, Sakai T, Yamamoto H, Takeuchi H, Kawashima Y . Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. Int J Pharm. 2008; 354(1-2):210-6. DOI: 10.1016/j.ijpharm.2007.11.002. View

5.
Patil Y, Swaminathan S, Sadhukha T, Ma L, Panyam J . The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials. 2009; 31(2):358-65. PMC: 2783414. DOI: 10.1016/j.biomaterials.2009.09.048. View